Developing novel Ca-zeolite/poly(amino acid) composites with hemostatic activity for bone substitute applications

Current bone substitute materials often lack sufficient mechanical strength and hemostatic properties. While poly(amino acid) (PAA) polymers offer biocompatibility, they may not meet the mechanical demands of load-bearing implants. Additionally, hemostatic activity is critical in surgical settings to control bleeding. Prior research has shown that composites with bioactive ceramics can enhance osseointegration, but few studies have combined these properties with hemostatic function. This gap motivated the development of Ca-zeolite/PAA composites. No prior work had resolved how to integrate hemostasis with structural stability in bone substitutes. The need for a material that supports both mechanical integrity and rapid blood clotting remains unmet. Researchers have explored various ceramic-polymer systems, but few have tested their performance in both mechanical and biological contexts. This paper aims to address that limitation by introducing a novel composite with dual functionality.

The study aimed to develop a novel composite material combining Ca-zeolite (CaY) with poly(amino acid) (PAA) to serve as a bone substitute with hemostatic properties. The specific problem addressed is the need for a material that supports both structural load-bearing and rapid blood coagulation during surgical implantation. The motivation stems from the limitations of existing materials, which often lack either mechanical strength or hemostatic activity. The researchers sought to evaluate the mechanical, degradative, and biological properties of the composite. They also aimed to assess its bioactivity and cytocompatibility in vitro. The goal was to determine whether the composite could meet the dual requirements of bone substitution and hemostasis. The study focused on characterizing the composite’s performance in simulated physiological conditions. The authors sought to provide evidence that the material could be suitable for clinical applications. This work contributes to the ongoing development of multifunctional biomaterials.

The researchers prepared CaY/PAA composites using an in situ melting polymerization method. Ca-zeolite (CaY) was synthesized from NaY zeolite through an ion-exchange process with Ca²⁺ ions. The composite’s composition and structure were analyzed using standard analytical techniques. Mechanical properties were evaluated through compressive strength testing. In vitro degradability was assessed by measuring weight loss in phosphate-buffered saline (PBS) over 16 weeks. Bioactivity was determined by observing apatite layer formation on the composite surfaces. Cytocompatibility was tested using mesenchymal stem cells (MSCs) cultured in extract solutions. Hemostatic activity was evaluated through in vitro coagulation tests. The study combined material science and biological testing to assess the composite’s suitability for bone substitutes.

The compressive strength of the CaY/PAA composites ranged from 145 to 186 MPa, indicating adequate mechanical strength for load-bearing applications. After 16 weeks in PBS, the 25CaY/PAA and 50CaY/PAA composites showed weight losses of 4.1 and 1.6 wt%, respectively. The pH of the PBS solution increased to 8.0 within two weeks and stabilized at 7.4, suggesting good stability. Scanning electron microscopy revealed apatite layer formation on the composite surfaces, confirming bioactivity. MSCs cultured in extract solutions showed high proliferation and good spreading on the composite surfaces. Cells on the composites exhibited higher alkaline phosphatase (ALP) activity, suggesting enhanced differentiation potential. In vitro coagulation tests showed shorter clotting times compared to other samples, indicating improved hemostatic performance. The composites demonstrated a combination of mechanical strength, bioactivity, and hemostatic activity.

The study demonstrated that CaY/PAA composites possess sufficient mechanical strength for bone substitute applications. The composites showed good stability in PBS, with minimal weight loss over 16 weeks. Bioactivity was confirmed through apatite layer formation on the surfaces. MSCs exhibited high proliferation and ALP activity, indicating favorable cytocompatibility. The composites outperformed other samples in in vitro coagulation tests, showing enhanced hemostatic activity. These findings suggest that the material could be suitable for clinical use in bone substitution. The authors propose that the combination of mechanical and hemostatic properties makes the composite a promising candidate for orthopedic implants. The results support further investigation into the material’s in vivo performance and long-term stability.